BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schröter J, Popp B, Brennenstuhl H, Döring JH, Donze SH, Bijlsma EK, van Haeringen A, Huhle D, Jestaedt L, Merkenschlager A, Arelin M, Gräfe D, Neuser S, Oates S, Pal DK, Parker MJ, Lemke JR, Hoffmann GF, Kölker S, Harting I, Syrbe S. Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsies. Eur J Hum Genet 2022;30:298-306. [PMID: 35017693 DOI: 10.1038/s41431-021-01027-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Syrbe S. Genetische Aspekte kindlicher Epilepsiesyndrome. Kinder- und Jugendmedizin 2022;22:309-323. [DOI: 10.1055/a-1915-9895] [Reference Citation Analysis]
2 Syrbe S. Developmental and epileptic encephalopathies – therapeutic consequences of genetic testing. Medizinische Genetik 2022;34:215-224. [DOI: 10.1515/medgen-2022-2145] [Reference Citation Analysis]
3 . Multiple drugs. Reactions Weekly 2022;1910:324-324. [DOI: 10.1007/s40278-022-17159-y] [Reference Citation Analysis]
4 Schröter J, Syring H, Göhring G, Kölker S, Opladen T, Hoffmann GF, Syrbe S, Jung-klawitter S. Generation of an induced pluripotent stem cell line (DHMCi008-A) from an individual with TUBA1A tubulinopathy. Stem Cell Research 2022;62:102818. [DOI: 10.1016/j.scr.2022.102818] [Reference Citation Analysis]
5 McNeill A. Good genotype-phenotype relationships in rare disease are hard to find. Eur J Hum Genet 2022;30:251. [PMID: 35260823 DOI: 10.1038/s41431-022-01062-5] [Reference Citation Analysis]